ArticleMolecular diversity2025

Valencene as a novel potential downregulator of THRB in NSCLC: network pharmacology, molecular docking, molecular dynamics simulation, ADMET analysis, and in vitro analysis.

Janmejay Pant et al.PubMed ↗Publisher ↗

No numbers read from the abstract.